Anything to declare? Competing interests in mental health nursing journals

Journal of Psychiatric and Mental Health Nursing

Volumn 11, Issue 5, 2004, Pages 620-622

  Carver, Neil ^a,c   Ashmore, Russell ^b,c  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b UNIVERSITY OF NORTHERN BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; INFORMATION DISSEMINATION; INTERPERSONAL COMMUNICATION; MEDICAL INFORMATION; MEDICAL LITERATURE; MENTAL HEALTH CARE; NOTE; NURSING; PRACTICE GUIDELINE; RELIABILITY;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

CONFLICT OF INTEREST; EDITORIAL POLICIES; ENGLAND; ETHICS, NURSING; HUMANS; PERIODICALS; PSYCHIATRIC NURSING;

EID: 4944232225     PISSN: 13510126     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2850.2004.00756.x     Document Type: Note

References (12)

1. Baker C.B., Johnsrud M.T., Crismon M.L., Rosenheck R.A. & Woods S.W. (2003) Quantitative analysis of sponsorship bias in economic studies of antidepressants. British Journal of Psychiatry 183, 498-506.
2. Barnett A. (2003) Revealed: how drug firms 'hoodwink' medical journals. Available at: http://observer.guardian.co.uk/print/0,3858,4813867-102285,00.html (accessed on 17 December 2003).
3. Davidoff F., DeAngelis C.D., Drazen J., Hoey J., Højgaard L., Horton R., Kotzin S., Nicholls M., Nylenna M., Overbeke A., Sox H., Van Der Weydon M. & Wilkes M. (2001) Sponsorship, authorship, and accountability. Lancet 358, 854-856.
4. Hemingway S. (2003) Mental health nursing and the pharmaceutical industry. Mental Health Practice 7, 22-23.
5. Hemingway S., Mitchell S., Fenwick M. & Coates K. (2003) Nurse prescribing: the USA experience. Mental Health Nursing 23, 21.
6. Kjaergard L. & Als-Nielson B. (2002) Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. British Medical Journal (BMJ.com) 325, 249-252.
7. Lexchin J., Bero L., Djulbeovic B. & Clark O. (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. British Medical Journal 326, 1167-1170.
8. Meikle J. (2004) Lancet regrets MMR report. The Guardian, Saturday 21 February, p. 6.
9. Melander H., Ablqvist-Rastad J., Meijer G. & Beerman B. (2003) Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. British Medical Journal 326, 1171-1173.
10. Monbiot G. (2004) The corporate stooges who nobble serious science. The Guardian, Tuesday 24 February, p. 26.
11. Van Kolfschooten F. (2002) Can you believe what you read? Nature 416, 360-363.
12. Wager E. (2003) How to dance with porcupines: rules and guidelines on doctors' relationships with drug companies. British Medical Journal 326, 1196-1198.